HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Linke, A. Articles by Hintze, T. H. Search for Related Content PubMed PubMed Citation Articles by Linke, A. Articles by Hintze, T. H.

Shift in metabolic substrate uptake by the heart during development of alloxan-induced diabetes

Department of Physiology, New York Medical College, Valhalla, New York 10595

Submitted 25 July 2002 ; accepted in final form 2 May 2003

Inhibition of endothelial nitric oxide (NO) synthase (eNOS) is associated with an increase in glucose uptake by the heart. We have already shown that Type I diabetes also causes a decrease in eNOS protein expression and altered NO control of both coronary vascular resistance and oxygen consumption. Therefore, we predict that the increase in plasma glucose and the reduction in eNOS during diabetes together would result in a large increase in cardiac glucose uptake. Arterial (A) and coronary sinus (C) plasma levels of glucose, free fatty acid (FFA), -hydroxybutyric acid (-HBA), and lactate were measured, and myocardial uptake was calculated before and at week 1, 2, 3, and 4 of alloxan-induced diabetes. The heart of healthy dogs consumed FFA (19.2 ± 2.6 µeq/min) and lactate (19.7 ± 3.4 µmol/min). Dogs in the late stage of diabetes (at week 4) had elevated arterial -HBA concentrations (1.6 ± 0.7 µmol/l) that were accompanied by an increased -HBA uptake (0.3 ± 0.2 µmol/min). In contrast, myocardial lactate (–4.8 ± 3.0 µmol/min) and FFA uptake (2.5 ± 1.9 µeq/min) were significantly reduced in diabetic animals. Despite a marked hyperglycemia (449 ± 25 mg/dl), the heart did not take up glucose (–7.9 ± 4.1 mg/dl). Our results indicate significant changes in the myocardial substrate utilization in dogs only in the late stage of diabetes, at a time when myocardial NO production is already decreased.

lactate; free fatty acids; glucose; keto acids; myocardium

This article has been cited by other articles:

				J. G. Williams, C. Ojaimi, K. Qanud, S. Zhang, X. Xu, F. A. Recchia, and T. H. Hintze Coronary nitric oxide production controls cardiac substrate metabolism during pregnancy in the dog Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2516 - H2523. [Abstract] [Full Text] [PDF]

				E. K. Walsh, H. Huang, Z. Wang, J. Williams, R. de Crom, R. van Haperen, C. I. Thompson, D. J. Lefer, and T. H. Hintze Control of myocardial oxygen consumption in transgenic mice overexpressing vascular eNOS Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2115 - H2121. [Abstract] [Full Text] [PDF]